| Patent | Date |
|---|
Pharmaceutical Compositions For Combination Therapy
App 20220280533 - PRUZANSKI; Mark ; et al. | 2022-09-08 |
Pharmaceutical Compositions For Combination Therapy
App 20220280534 - PRUZANSKI; Mark ; et al. | 2022-09-08 |
Compositions Of Obeticholic Acid And Methods Of Use
App 20220133745 - LANCASTER; Richard Gail ; et al. | 2022-05-05 |
Pharmaceutical compositions for combination therapy
Grant 11,311,557 - Pruzanski , et al. April 26, 2 | 2022-04-26 |
Treatment Of Fibrosis Using Fxr Ligands
App 20210346400 - FIORUCCI; Stefano ; et al. | 2021-11-11 |
Treatment of fibrosis using FXR ligands
Grant 10,987,362 - Fiorucci , et al. April 27, 2 | 2021-04-27 |
FXR agonist compositions for combination therapy
Grant 10,894,054 - Pruzanski , et al. January 19, 2 | 2021-01-19 |
Treatment Of Fibrosis Using Fxr Ligands
App 20200397803 - Fiorucci; Stefano ; et al. | 2020-12-24 |
Compositions of obeticholic acid and methods of use
Grant 10,758,549 - Lancaster , et al. Sep | 2020-09-01 |
Compositions of obeticholic acid and methods of use
Grant 10,751,349 - Lancaster , et al. A | 2020-08-25 |
Treatment Of Fibrosis Using Fxr Ligands
App 20200197414 - Fiorucci; Stefano ; et al. | 2020-06-25 |
Compositions Of Obeticholic Acid And Methods Of Use
App 20200171053 - Lancaster; Richard Gail ; et al. | 2020-06-04 |
Compositions of obeticholic acid and methods of use
Grant 10,646,499 - Lancaster , et al. | 2020-05-12 |
Compositions Of Obeticholic Acid And Methods Of Use
App 20200054650 - Lancaster; Richard Gail ; et al. | 2020-02-20 |
Compositions Of Obeticholic Acid And Methods Of Use
App 20200046735 - Lancaster; Richard Gail ; et al. | 2020-02-13 |
Compositions Of Obeticholic Acid And Methods Of Use
App 20200046736 - Lancaster; Richard Gail ; et al. | 2020-02-13 |
Compositions Of Obeticholic Acid And Methods Of Use
App 20190255071 - Lancaster; Richard Gail ; et al. | 2019-08-22 |
Treatment of fibrosis using FXR ligands
Grant 10,258,633 - Fiorucci , et al. | 2019-04-16 |
Compositions Of Obeticholic Acid And Methods Of Use
App 20190076446 - Lancaster; Richard Gail ; et al. | 2019-03-14 |
Compositions of obeticholic acid and methods of use
Grant 10,052,337 - Lancaster , et al. August 21, 2 | 2018-08-21 |
Pharmaceutical Compositions For Combination Therapy
App 20180117065 - PRUZANSKI; Mark ; et al. | 2018-05-03 |
Treatment of Pulmonary Disease
App 20180064729 - Pruzanski; Mark ; et al. | 2018-03-08 |
Pharmaceutical Compositions For Combination Therapy
App 20180008616 - Pruzanski; Mark ; et al. | 2018-01-11 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 9,763,964 - Pellicciari , et al. September 19, 2 | 2017-09-19 |
Treatment Of Fibrosis Using Fxr Ligands
App 20170165277 - Fiorucci; Stefano ; et al. | 2017-06-15 |
Compositions Of Obeticholic Acid And Methods Of Use
App 20170035784 - Lancaster; Richard Gail ; et al. | 2017-02-09 |
Treatment of fibrosis using FXR ligands
Grant 9,498,484 - Fiorucci , et al. November 22, 2 | 2016-11-22 |
Treatment of Pulmonary Disease
App 20160213689 - Pruzanski; Mark ; et al. | 2016-07-28 |
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions
App 20150359805 - Pellicciari; Roberto ; et al. | 2015-12-17 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 9,090,652 - Pellicciari , et al. July 28, 2 | 2015-07-28 |
Treatment of Pulmonary Disease
App 20140148428 - Pruzanski; Mark ; et al. | 2014-05-29 |
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions
App 20140057886 - Pellicciari; Roberto ; et al. | 2014-02-27 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 8,546,365 - Pellicciari , et al. October 1, 2 | 2013-10-01 |
Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions
App 20120283234 - Pellicciari; Roberto ; et al. | 2012-11-08 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 7,932,244 - Pellicciari , et al. April 26, 2 | 2011-04-26 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Grant 7,858,608 - Pellicciari , et al. December 28, 2 | 2010-12-28 |
Bile Acid Derivatives As Fxr Ligands For The Prevention Or Treatment Of Fxr-mediated Diseases Or Conditions
App 20100063018 - Pellicciari; Roberto ; et al. | 2010-03-11 |
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
App 20080182832 - Pellicciari; Roberto ; et al. | 2008-07-31 |
Method of reducing drug-induced adverse side effects in a patient
App 20060252670 - Fiorucci; Stefano ; et al. | 2006-11-09 |
Treatment of fibrosis using FXR ligands
App 20060069070 - Fiorucci; Stefano ; et al. | 2006-03-30 |
| 